Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, Imbesi V, Molteni M, Danelli PG, Taschieri AM, Bianchi Porro G.

Gastroenterology. 2004 Sep;127(3):730-40.

PMID:
15362028
2.

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH.

Gastroenterology. 2004 Sep;127(3):723-9.

PMID:
15362027
3.

Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.

Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, Frigo AC, Fazio V, Marabotto E, Savarino V.

Am J Gastroenterol. 2013 Nov;108(11):1731-42. doi: 10.1038/ajg.2013.287. Epub 2013 Sep 10.

PMID:
24019080
4.

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.

Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P, Genser D, Petritsch W, Raithel M, Hoffmann R, Gross V, Plauth M, Staun M, Nesje LB.

Gastroenterology. 2000 Feb;118(2):264-73. Erratum in: Gastroenterology 2000 Jul;119(1):280.

PMID:
10648454
5.

[Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].

Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J.

Gastroenterol Hepatol. 2000 Oct;23(8):374-8. Spanish.

PMID:
11227650
6.

Interventions for prevention of post-operative recurrence of Crohn's disease.

Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006873. doi: 10.1002/14651858.CD006873.pub2. Review.

PMID:
19821389
7.

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR; International AZT-2 Study Group.

Gut. 2010 Jun;59(6):752-9. doi: 10.1136/gut.2009.194159.

PMID:
20551460
8.

[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].

Karoui S, Kallel L, Boubaker J, Filali A.

Tunis Med. 2006 Oct;84(10):595-8. Review. French.

PMID:
17193847
9.
10.

Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.

Boyapati RK, Torres J, Palmela C, Parker CE, Silverberg OM, Upadhyaya SD, Nguyen TM, Colombel JF.

Cochrane Database Syst Rev. 2018 May 12;5:CD012540. doi: 10.1002/14651858.CD012540.pub2. Review.

11.

Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.

Papamichael K, Archavlis E, Lariou C, Mantzaris GJ.

J Crohns Colitis. 2012 Oct;6(9):924-31. doi: 10.1016/j.crohns.2012.02.012. Epub 2012 Mar 15.

PMID:
22424843
12.

Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.

Yamamoto T, Umegae S, Matsumoto K.

Inflamm Bowel Dis. 2009 Oct;15(10):1460-6. doi: 10.1002/ibd.20915.

PMID:
19266566
13.

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.

Armuzzi A, Felice C, Papa A, Marzo M, Pugliese D, Andrisani G, Federico F, De Vitis I, Rapaccini GL, Guidi L.

J Crohns Colitis. 2013 Dec;7(12):e623-9. doi: 10.1016/j.crohns.2013.04.020. Epub 2013 Jun 27.

PMID:
23810678
14.

Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.

Mowat C, Arnott I, Cahill A, Smith M, Ahmad T, Subramanian S, Travis S, Morris J, Hamlin J, Dhar A, Nwokolo C, Edwards C, Creed T, Bloom S, Yousif M, Thomas L, Campbell S, Lewis SJ, Sebastian S, Sen S, Lal S, Hawkey C, Murray C, Cummings F, Goh J, Lindsay JO, Arebi N, Potts L, McKinley AJ, Thomson JM, Todd JA, Collie M, Dunlop MG, Mowat A, Gaya DR, Winter J, Naismith GD, Ennis H, Keerie C, Lewis S, Prescott RJ, Kennedy NA, Satsangi J; TOPPIC Study Group.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):273-282. doi: 10.1016/S2468-1253(16)30078-4. Epub 2016 Aug 30.

15.

Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.

Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, Papi C, Viscido A, Cammà C, Corrao G, Latella G.

Aliment Pharmacol Ther. 2003 Feb 15;17(4):517-23.

16.

Aminosalicylates for induction of remission or response in Crohn's disease.

Lim WC, Wang Y, MacDonald JK, Hanauer S.

Cochrane Database Syst Rev. 2016 Jul 3;7:CD008870. doi: 10.1002/14651858.CD008870.pub2. Review.

17.

Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.

Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.

Ther Drug Monit. 2007 Feb;29(1):1-5.

PMID:
17304143
18.

Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

Gordon M, Naidoo K, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008414. doi: 10.1002/14651858.CD008414.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Jun 20;6:CD008414.

PMID:
21249709
19.

6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

Hayee BH, Harris AW.

Gastroenterology. 2005 Jan;128(1):249; author reply 249-51. No abstract available.

PMID:
15633158
20.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Chande N, Townsend CM, Parker CE, MacDonald JK.

Cochrane Database Syst Rev. 2016 Oct 26;10:CD000545. Review.

Supplemental Content

Support Center